The Real-World Cost Study of Treating mCRC with Bevacizumab Followed by EGFRi in WT KRAS patients

Authors

SEHNALOVÁ Irena ŘÍHOVÁ Barbora DEMLOVÁ Regina

Year of publication 2019
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info